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Abstract
Background: Quality indicators are increasingly used to measure the quality of care and compare quality across
hospitals. In the Netherlands over the past few years numerous hospital quality indicators have been developed
and reported. Dutch indicators are mainly based on expert consensus and face validity and little is known about
their construct validity. Therefore, we aim to study the construct validity of a set of national hospital quality
indicators for hip replacements.
Methods: We used the scores of 100 Dutch hospitals on national hospital quality indicators looking at care
delivered over a two year period. We assessed construct validity by relating structure, process and outcome
indicators using chi-square statistics, bootstrapped Spearman correlations, and independent sample t-tests. We
studied indicators that are expected to associate as they measure the same clinical construct.
Result: Among the 28 hypothesized correlations, three associations were significant in the direction
hypothesized. Hospitals with low scores on wound infections had high scores on scheduling postoperative
appointments (p-value = 0.001) and high scores on not transfusing homologous blood (correlation coefficient = -0.28;
p-value = 0.05). Hospitals with high scores on scheduling complication meetings, also had high scores on providing
thrombosis prophylaxis (correlation coefficient = 0.21; p-value = 0.04).
Conclusion: Despite the face validity of hospital quality indicators for hip replacement, construct validity seems to be
limited. Although the individual indicators might be valid and actionable, drawing overall conclusions based on the
whole indicator set should be done carefully, as construct validity could not be established. The factors that may
explain the lack of construct validity are poor data quality, no adjustment for case-mix and statistical uncertainty.
Keywords: Hip replacement, Database, Health care quality, Quality indicators, Validity
Background
As quality improvement becomes a central tenet of
health care, quality indicators (QIs) are becoming in-
creasingly important. Quality is monitored and publicly
reported in order to provide patients and health insurers
with information regarding choices and to improve the
quality of the underlying complex and resource-
intensive care procedures [1].
For such purposes QIs need to be based on reliable
data [2, 3], and they must cover quality aspects on a
structural, process, and outcome level [4]. The under-
lying assumption is that good structures of care increase
the likelihood of good processes and good processes in-
crease the likelihood of good outcomes (the Donabedian
framework) [4]. Another important prerequisite for the
external use of the indicators and fair comparison of
hospitals is that QIs are valid [5] and actionable. QIs
need to provide insight into which factors determine the
occurrence of an outcome, so that hospitals are able to
act on the process to improve the outcome.
Total hip replacements are interesting for quality of
care research because hip replacements are common,
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elective procedures that are being performed more and
more frequently [6]. Although the clinical and economic
effectiveness of hip replacements is proven [7], it is still
possible to observe variation in performance between
providers [8, 9]. As a result, these orthopaedic proce-
dures have for instance been included in pay-for-
performance schemes by social insurance programs
such as Medicare and Medicaid [10]. In such a pro-
gram hospitals are rewarded for meeting pre-defined
performance targets related to the health care that is
delivered [11]. In the pay-for-performance scheme of
Medicare and Medicaid, the so-called ‘Premier Quality
Initiative Demonstration’, a composite score was cre-
ated from three measures of surgical process quality
and three measures of surgical outcome. A perform-
ance bonus consisting of two percent of diagnosis-related
group payments for total hip and knee arthroplasty
was given to hospitals that scored in the top 10% on
the composite measure [10]. For such external use (as
well as for internal use such as in local hospital qual-
ity improvement), it is critical that indicators present
a valid picture of the quality of the health care that is
provided by a hospital [5]. However, empirical evalua-
tions of the relation between outcome indicators and
process and structure indicators that measure the
same construct are scarce in Europe [12]. Even if
quality indicators are tested in different health care
systems, an evaluation in the health care system in
which the indicator is used is essential. Differences in
national health care and local hospital organization
may influence the indicator’s validity [1]. Insight into
the validity of QIs is particularly important when data
reliability is at stake, for instance when there are no
national standards that hospitals or database software
providers should follow when setting up their in-
hospital quality registries in which the quality data is
entered [1, 2]. This is the case in the Netherlands,
where QIs were developed by the Dutch Health Care
Transparency Program (DHTP) through a combin-
ation of expert consensus and available scientific
literature. They were tested in only a few hospitals.
Employees of the hospitals are required to calculate
and report these QIs annually to the DHTP; public
reporting and publication of these QIs has occurred
for several subsequent years [13].
Therefore we aimed to evaluate several publicly
available indicators of quality of hospital care in the
Netherlands related to hip replacements (15 indica-
tors) with regard to their construct validity, or the
“degree to which an indicator measures what it claims
to be measuring” [14]. In this study construct validity
is operationalized by a significant associationbetween
two quality indicators that measure the same under-
lying construct in the expected direction.
Methods
We conducted a cross-sectional data analysis, using
quantitative data from two registration years (2008 and
2009) as reported by the hospitals.
QIs under investigation
The QIs we evaluated are all related to pre-operative
and post-operative health care for hip replacements. We
used data from two consecutive years. Table 1 shows an
overview of the definitions, numerators (i.e. number of
patients who underwent a certain care process) and
denominators (i.e. total number of patients) of the struc-
ture, process and outcome (S-P-O) QIs evaluated in this
study. Moreover, it can be seen that the structure QIs in
the hip replacement set are dichotomous (yes/no),
whereas the majority of the process and outcome indica-
tors are continuous measures (a proportion of patients
with particular treatment or outcome).
Data source
Dutch health care transparency program data (DHTP)
The QI data originate from a national database hosted
by the DHTP [15]. Dutch hospital staff annually collect
and submit to DHTP hospital-specific performance
scores (numerators and denominators) for various
diseases and interventions based on health care delivered
in the preceding calendar year.
Although we had data on indicator scores for three
subsequent years (2008, 2009, 2010) we only could
include indicator scores from two years (2008, 2009) in
our study. This is due to major changes in the indica-
tors, which would have influenced the comparability of
the indicator scores between the years. For our study we
selected the available numerators and denominators for
each hospital and indicator. All QI scores were aggre-
gated on the hospital level (Table 1).
Analysis
To describe the range in scores across hospitals we
calculated the mean and interquartile range (IQR) of all
indicator scores and denominators on the hospital level.
Based on the indicator manual, the literature and
medical expert opinion, we hypothesized 28 associations
between hip replacement indicators that measure the
same underlying construct. Table 2 shows an overview
of the hypothesized indicator associations and their
direction of association.
To initially investigate the relationship between con-
tinuous structure, process and outcome indicators, we
used non-parametric Spearman correlations. To assess
the uncertainty in the estimated correlation coefficient
we calculated 95 % confidence intervals. To give a more
robust estimation, these intervals were additionally esti-
mated (bootstrapped) based on 1000 random replicas
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(fictitious hospitals) that were constructed from the
original dataset. The relationships between the dichot-
omous structure indicators were analysed by means of
chi-square tests. Finally, to examine the relationship be-
tween dichotomous structure and continuous process/
outcome indicators independent sample t-tests were ap-
plied. Here we also bootstrapped 1000 random replicas.
Analyses were conducted in the statistical programs
SPSS version 21. Significance was set at α < 0.05. P-values
below 0.1 were regarded as marginally significant.
Results
On average 64 hospitals provided data to calculate indi-
cator scores in year 2008, from a total of 100 available
hospitals in the Netherlands. The participation increased
in subsequent year, in which on average 95 % of the
hospitals provided data. Many indicator scores improved
from 2008 to 2009. For example, the percentage of
wound infections ranged from 0 to 3 % across hospitals
in 2008, while in 2009 the range was from 0 to 0.03 %
(Table 3).
Based on their face validity and on the literature, we
hypothesized 28 associations (hypothesized associations,
ha) to be significant. We found three of these correla-
tions to be significant in the direction hypothesized, of
which one was found in the data from 2008 and two
were found in the data from 2009 (ha 7, ha 8, ha 19).
As expected, hospitals that reported planning appoint-
ments within six weeks after surgery 0.01 % reported
deep wound infections, compared to 0.02 % of those
who did not report to plan postoperative appointments
within six weeks (p-value = 0.001). Further, our analysis
showed that hospitals with a higher percentage of
patients who did not receive a homologue blood transfu-
sion had a lower percentage of wound infections,
although this correlation was only marginally significant
(ha 7: r = -0.28, p-value = 0.05). Hospitals that had high
scores on the number of complication meetings also had
Table 1 Included DHTP total hip replacement quality indicators
Total hip replacement
Qi numbera Qi name Indicator typeb QI definition
qi1 Preoperative patient
information
S Definition: hospitals provide written or audio-visual preoperative patient information (yes/no)
qi2a Guideline thrombosis
prophylaxis
S Definition: hospitals have a guideline or protocol on thrombosis prophylaxis for cases of hip
replacement (yes/no)
qi2b Thrombosis
prophylaxis
P Definition and Numerator: in hip replacement cases, the number of operations in which
patients received medical thrombosis prophylaxis within 6 weeks and no more than 3 months
after the operation
qi3a Complication register S Definition: an automated information system is available to provide insight into the occurrence
of complications (e.g. wound infection, lung emboli) within 6 weeks of HR (yes/no)
qi3b Appointment within
6 weeks
S Definition: to detect complications, a postoperative appointment is held within 6 weeks of a
hip replacement (yes/no)
qi3c Orthopaedic
registration form
S Definition: in hip replacement cases, an orthopaedic registration form is used to register
complications (yes/no)
qi3d Complications
meeting
S Definition: minuted meetings are held to discuss hip-replacement complications
(number of meetings per year)
qi3e Improvement plan S Definition: minuted meetings are held to discuss hip-replacement complications, if necessary
an improvement plan with the person in charge is assigned (yes/no)
qi4a Blood management
guideline
S Definition: a blood-management guideline or protocol to reduce perioperative administered in
case of hip replacement is present (yes/no)
qi4b Transfusion of
homologue blood
P Definition and Numerator: in hip replacement cases, the number of operations in which
patients did not receive transfusion of homologue blood
qi5a Guideline for
antibiotic prophylaxis
S Definition: a guideline/protocol is available for antibiotic prophylaxis in the event of hip
replacement (yes/no)
qi5b Perioperative
antibiotics
P Definition and Numerator: in hip replacement cases, the number of operations in which
perioperative antibiotics were administered
qi5c Antibiotics 60–15 min P Definition and Numerator: in hip replacement cases, the number of operations in which
patients received antibiotics 60 to 15 min before incision
qi5d Wound infection O Definition and Numerator: in hip replacement cases, the number of patients with deep wound
infections within 6 weeks of the operation
qi6 National prosthetic
register
S Definition: the hospital participates in the national arthroplasty register (yes/no)
aAccording to number in DHTP hip and knee replacement indicator set
bS structure, P process, O outcome
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Table 2 Hypothesized indicator association and direction of association
Hypothesized indicator associations Evidence
for
expected
indicator
association
Expected
correlation
association
p-value
indicator
Association
strength
2008 2009
haa 1 having a thrombosis prophylaxis management guideline (qi2ab) and the percentage of patients who
accurately receive a thrombosis prophylaxis (qi2b)
[29] positive / /
ha 2 having a blood management guideline (qi4a) and the percentage of patients who do not receive a
blood transfusion (qi4b)
[29, 30] positive / /
ha 3 having a guideline for antibiotic prophylaxis (qi5a) and the percentage of patients who receive
antibiotic prophylaxis perioperative (qi5b) [25]
[29] positive / /
ha 4 having a guideline for antibiotic prophylaxis (qi5a) and the percentage of patients who receive
antibiotic prophylaxis 60–15 min before incision (qi5c) [25]
[29] positive / /
ha 5 the percentage of patients who receive their perioperative antibiotic prophylaxis in a timely manner
(qi5b) and the percentage of patients with deep wound infection (qi5d) [26–28]
[30–32] negative / 0.74
ha 6 the percentage of patients that receive antibiotic prophylaxis 60–15 min before incision (qi5c)
and the percentage of patients with deep wound infection (qi5d) [26–28]
[30–32] negative 0.14 0.74
ha 7 the percentage of patients who receive no blood transfusion (qi4b) and the percentage of patients
with deep wound infection (qi5d) [29, 30]
[33, 34] negative 0.05 0.07
ha 8 having a timely postoperative appointment (q3b) and the percentage of deep
wound infections (qi5d)
negative / 0.001
ha 9 having a complication register (qi3a) and providing a thrombosis prophylaxis (qi2b) positive 0.73 0.19
ha 10 having a complication register (qi3a) and the percentage of patients receiving no
blood transfusion (qi4b)
positive 0.09 0.57
ha 11 having a complication register (qi3a) and the percentage of patients receiving perioperative antibiotic
prophylaxis (qi5b)
positive / 0.60
ha 12 having a complication register (qi3a) and the percentage of patients receiving antibiotic prophylaxis
60–15 min before incision (qi5c)
positive 0.29 0.57
ha 13 having a complication register (qi3a) and the percentage of patients with deep wound infection
(qi5d)
negative 0.74 0.43
ha 14 having an orthopaedic registration form (qi3c) and the percentage of patients receiving thrombosis
prophylaxis (qi2b)
[35] positive 0.80 0.89
ha 15 having an orthopaedic registration form (qi3c) and the percentage of patients receiving no blood
transfusion (qi4b)
[35] positive 0.98 0.26
ha 16 having an orthopaedic registration form (qi3c) and the percentage of patients receiving perioperative
antibiotic prophylaxis (qi5b)
[35] positive / 0.06
ha 17 having an orthopaedic registration form (qi3c) and the percentage of patients receiving antibiotic
prophylaxis 60–15 min before incision (qi5c) [31]
[35] positive / 0.28
ha 18 having an orthopaedic registration form (qi3c) and the percentage of patients with deep wound
infections (qi5d) [31]
[35] positive 0.60 0.42
ha 19 having complication meetings (qi3d) and the percentage of patients receiving thrombosis
prophylaxis (qi2b)
positive 0.50 0.04
ha 20 having complication meetings (qi3d) and the percentage of patients receiving no blood transfusion
(qi4b)
positive 0.26 0.91
ha 21 having complication meetings (qi3d) and the percentage of patients receiving perioperative antibiotic
prophylaxis (qi5b)
positive / 0.16
ha 22 having complication meetings (qi3d) and the percentage of patients receiving antibiotic prophylaxis
60–15 min before incision (qi5c)
positive 0.26 0.32
ha 23 having complication meetings (qi3d) and the percentage of patients with deep wound
infections (qi5d)
negative 0.39 0.91
ha 24 having an improvement plan to avoid complications (qi3e) and the percentage of patients receiving
thrombosis prophylaxis (qi2b)
positive 0.86 0.52
ha 25 having an improvement plan to avoid complications (qi3e) and the percentage of patients receiving
no blood transfusion (qi4b)
positive 0.09 0.17
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high scores on providing thrombosis prophylaxis (ha 19:
r = 0.21, p-value = 0.04).
We found several indicator associations, which were
not a priori expected.
We found two significant structure-structure associa-
tions. We observed that hospitals that maintained a
complication registration were also more likely to score
high on planning a postoperative appointment within six
weeks post-surgery (χ2: 19.97, p-value < 0.01). Further,
hospitals that reported holding complication meetings,
11 % reported to use an improvement plan compared to
0 % of those who did not report to hold complication
meetings (p-value = 0.01). We also observed several
process-process associations. Primarily, the administra-
tion of thrombosis prophylaxis correlated significantly
with the administration of antibiotic prophylaxis, sug-
gesting that hospitals that accurately administer throm-
bosis prophylaxis were more likely to accurately
administer antibiotic prophylaxis to their patients (r =
0.27, p-value < 0.05) and, secondly, managed to do it in
time (r = 0.28, p-value < 0.05).
We additionally observed a significant correlation
between the administration of antibiotic prophylaxis and
the administration of antibiotic prophylaxis in a timely
manner (Spearman R = 0.46, p-value < 0.01).
Having an improvement plan was related to the per-
centage of patients who received their antibiotic prophy-
laxis in a timely manner; however, they were related
differently than might be expected. Of hospitals having
an improvement plan, 98 % reported to provide anti-
biotic prophylaxis, compared to 100 % of those who do
not have an improvement plan (p-value = 0.03) (Table 4).
Discussion
By associating structure, process, and outcome indicators
we measured the construct validity of national quality
indicators for hip replacement. Of the 28 a priori expected
associations (per year) only three were observed to be
Table 2 Hypothesized indicator association and direction of association (Continued)
ha 26 having an improvement plan to avoid complications (qi3e) and the percentage of patients receiving
perioperative antibiotic prophylaxis (qi5b)
positive / 0.39
ha 27 having an improvement plan to avoid complications (qi3e) and the percentage of patients receiving
antibiotic prophylaxis 60–15 min before incision (qi5c)
positive 0.51 0.05
ha 28 having an improvement plan to avoid complications (qi3e) and the percentage of patients with deep
wound infections (qi5d)
negative 0.26 0.72
a hypothesized association (ha), bquality indicator (qi)
Table 3 Hospital-level variation in total hip replacement scores in year 2008 and 2009
2008 2009
Indicator scores on
hospital level
Denominators on
hospital level
Indicator scores on
hospital level
Denominators on
hospital level
Nb mean IQR min-max median IQR Nb mean IQR mix-max mean IQR
qia1 preoperative patient information 68 1 1–1 1–1 / / 97 1 1–1 0–1 / /
qi2a guideline thrombosis prophylaxis 68 1 1–1 1–1 / / 68 1 1–1 1–1 / /
qi2b thrombosis prophylaxis 64 100 100–100 95–100 245 49–745 95 100 100–100 93–100 226 56–647
qi3a complication register 68 1 1–1 0–1 / / 97 1 1–1 0–1 / /
qi3b appointment within 6 weeks 68 1 1–1 1–1 / / 97 1 1–1 0–1 / /
qi3c orthopaedic register form 68 1 1–1 0–1 / / 97 1 1–1 0–1 / /
qi3d complication meeting 63 11 4–12 0–52 / / 96 11 4–12 0–260 / /
qi3e improvement plan 65 1 1–1 0–1 / / 96 1 1–1 0–1 / /
qi4a blood management guideline 68 1 1–1 1–1 / / 68 1 1–1 1–1 / /
qi4b transfusion of homologous blood 52 91 94–100 0–100 241 49–745 90 91 88–100 11–100 222 56–647
5a guideline for antibiotic prophylaxis 68 1 1–1 1–1 / / 68 1 1–1 1–1 / /
5b perioperative antibiotics 65 100 100–100 100–100 245 49–745 65 100 100–100 100–100 226 56–647
qi5c antibiotics 60–15 min 59 97 100–100 0–100 237 49–745 94 98 100–100 66–100 226 56–647
qi5d wound infections 60 1 0–1 0–3 245 49–745 93 0 0–0 0–0 213 52–647
qi6 countrywide implementation 68 1 1–1 0–1 / / 97 1 1–1 0–1 / /
average 64 X X X 95 X X X
aQuality indicator (qi)
bNumber of hospitals that delivered the indicator score
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significant in the direction hypothesized. Additionally
seven associations that were not a priori expected were
also found to be significant. None of the associations were
consistent over the two-year time period, despite the
scientific foundation of the quality indicators and overall
expert consensus regarding their validity. Therefore, the
construct validity of the quality indicator set under evalu-
ation seems limited. We only found three of the a priori
expected associations to be significant. For example, we
observed that in hospitals that scheduled an appointment
with a patient within six weeks after the patient’s hip
replacement, the number of relevant wound infections
after hip replacement was lower compared to hospitals
that did not plan such an appointment. This is consistent
with the international literature and with the widely held
opinion that an appointment within this period helps to
detect postoperative complications at an early stage, and
thereby prevent advanced severe wound infections [16].
We additionally observed several process-process associa-
tions, which in retrospect, might indicate an overall qual-
ity awareness culture on the hospital level. For example,
hospitals that had high scores on the administration of
perioperative antibiotics also had high scores on the
administration of antibiotics prior to the incision.
Our study showed limited construct validity between
the tested quality indicators. This finding is in line with
existing literature. Several studies tend to show relatively
weak associations between different types of quality
indicators in the health care field [17–20]. Associations
between quality indicators are complex and different
methodological factors influence the association between
them.
An important factor for construct validity is data reli-
ability. Although the data registration showed signs of
improvement in 2009 compared to 2008, data reliability
remained an issue in the data of the DHTP. In previous
studies it was found that differences in data collection
and reporting methods used by hospital employees, such
as the use of different indicator definitions, most likely
influenced the comparability of the DHTP data [2].
Moreover, many of the indicators are not very specific.
For instance, 9 of the 15 hip replacement indicators are
dichotomous indicators (yes/no). But for example the in-
dicator “availability of a guideline” (e.g. qi4a, qi5b), gives
no information about actual adherence to the guideline.
The lack of association we found among the indicators
may be explained by the limited variation and the small
numbers observed among many of the included quality
indicators. For example, in 2008 the average event rate
for patients developing wound infections was merely
1 %. When there are few observations and event rates
are that low, indicator scores will randomly fluctuate
over time, even if the underlying quality of care remains
constant [21].
Furthermore, an important factor influencing con-
struct validity is the extent of case-mix correction, as
case-mix factors make up a large part of observed
outcome variation [22]. Lack of adjustment for patient
characteristics, which are not related to quality of hos-
pital care but influence the patients’ risk for an outcome,
may lead to a biased reflection of quality of care and an
unfair comparison between hospitals. As aggregated
hospital-level data currently does not include informa-
tion on the underlying patient characteristics, a valid
and fair analysis between the hospitals cannot be
guaranteed.
As quality improvement has become a central tenet of
health care, QIs are becoming increasingly important.
Many countries have already started their own QI pro-
gram and many more are preparing to start QI programs
soon. Despite the increasing number of countries imple-
menting QI programs, the number of studies testing the
validity of indicators is limited. While a number of stud-
ies have tested the construct validity of indicators in the
U.S. [23–28], a limited number of such studies have
been conducted in the European health care setting [12].
However, given the differences in national health care
and local hospital organizations indicators should be
evaluated before they are adopted from another health
system. The validity of quality of care indicators cannot
be assumed for a health care setting outside of the one
where the indicator was developed and tested [1]. There-
fore further research on the validity of the currently used
indicators in the health care setting in which they are
used is warranted. Several methodological lessons can be
learned from our observations. In order for a QI to be
valid, it must be reliable [2]. An indicator’s reliability is
determined by the accuracy of the underlying data and
the unambiguousness definition of the indicator [2].
Moreover, when hospital employees are responsible for
collecting the data and computing the QIs, there needs
to be some central control over these processes. Further-
more, to increase data reliability the software market
should be regulated and standards should be set for the
development of automatic data extraction software. In
order to find relationships between indicators it is
crucial to take into account the influence of low event
rates and case-mix differences. Failing to adjust for these
factors may confound the relationship between quality
indicators.
Currently there is no gold standard on how to meas-
ure quality of care. We operationalized construct validity
by the association between two test scores. Usually, in
psychometric research, a person’s score on for example a
new psychological test is associated with a score on a
more established test measuring the same underlying
construct [14]. In our study both test scores were
derived from the same database and were both the
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subject of study. Merely the presence of a significant
association that was expected based on the literature
was considered to be a sign of construct validity of both
indicators. One could argue therefore that the method
of validity assessment in our study is not very strong. A
better way to assess the construct validity is to relate the
indicator scores of interest with measures derived from
other clinical databases. However, for countries in which
reliable health care databases are scarce ours is the only
approach possible. Second, the judgement on the
construct validity of an indicator is always arbitrary. In
our study we used a significant association in the
expected direction as an indication of construct validity;
however, most of the significant associations were weak.
Third, when assessing multiple associations one typically
corrects for multiple testing, for instance with a Bonferoni
correction. As we a priori planned our associations based
on the available scientific evidence, we did not correct for
multiple testing. However, we do realize that we have to
treat the observed significant associations with caution.
Further research and trend data is needed to test
construct validity over a longer time period in order to be
able to identify systematic indicator associations.
Conclusion
Overall it can be concluded that despite the face validity
of hospital quality indicators for hip replacement, con-
struct validity seems to be limited. Although the individual
indicators might be valid and actionable, drawing overall
conclusions based on the whole indicator set should be
done with caution, as construct validity could not be
established. Limitations of the quality indicators that likely
explain the lack of construct validity are poor data quality,
lack of adjustment for case-mix and statistical uncertainty.
Before any action can be taken based on the indicator
scores these limitations must be addressed.
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